Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-01-03 @ 9:50 PM
Study NCT ID:
NCT00000235
Status:
COMPLETED
Last Update Posted:
2005-08-17
First Post:
1999-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alternate Day Buprenorphine Administration, Phase XII - 17
Sponsor:
National Institute on Drug Abuse (NIDA)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NIDA-06969-17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |